Tango Therapeutics, Inc. · NASDAQ:TNGX

Raymond Debbane reported a 6.10% stake in Tango Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 13, 2026

Raymond Debbane reported a 6.10% stake in Tango Therapeutics, Inc., 8,165,374 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).

Stake
6.10%
Shares
8,165,374
Intent
Passive
What changed
Stake changed
Filed together
8 holders

The filing in full

HolderStakeShares
Invus Public Equities, L.P.5.30%7,068,444
Invus Public Equities Advisors, LLC5.30%7,068,444
Invus Global Management, LLC5.30%7,068,444
Siren, L.L.C.5.30%7,068,444
Avicenna Life Sci Master Fund LP0.80%1,096,930
Avicenna Life Sci Master GP LLC0.80%1,096,930
Ulys, L.L.C.0.80%1,096,930
Raymond Debbane6.10%8,165,374

Source

View original at SEC

Related